ClinicalTrials HQ

Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy

Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy

Enrolling by invitation · NCT04628585 · Registry updated 2025-03-20
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene TherapyCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell diseaseEnrolling by invitationNot stated2025-03-20NCT04628585

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Genetix Biotherapeutics Inc.7

16 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Ann & Robert H. Lurie Children's Hospital of ChicagoChicagoUnited States2
Baylor College of MedicineHoustonUnited States306
Children's Healthcare of AtlantaAtlantaUnited States47
Children's Hospital of PhiladelphiaPhiladelphiaUnited States434
Cohen Children's Medical CenterNew Hyde ParkUnited States16
Columbia University Medical centerNew YorkUnited States224
Duke University Medical CenterDurhamUnited States52
Hackensack University Medical CenterHackensackUnited States308
Hospital NeckerParisFrance1
Medical University of South CarolinaCharlestonUnited States628
The University of North CarolinaChapel HillUnited States1
UCSF Benioff Children's Hospital OaklandOaklandUnited States85
University of AlabamaBirminghamUnited States29
University of Minnesota Masonic Children's HospitalMinneapolisUnited States9
Virginia Commonwealth UniversityRichmondUnited States156
Warren Grant Magnuson Clinical CenterBethesdaUnited States1